Research Grant

[Cite as]

Researchers: Prof Lee Yong Lim (Principal investigator) ,  Prof Colin Raston

Brief description Many anticancer drugs have severe side effects due to their potency and non-specificity of action. To improve the treatment outcome for thousands of cancer patients, we aim to engineer calixarene-based nanocarriers that bypass normal tissues to selectively deposit drugs and imaging agents into tumour cells. Such delivery systems will optimize the performance of a host of anticancer agents that act within cells, and enable drug treatment and monitoring to be simultaneously realised.

Funding Amount $AUD 322,267.68

Funding Scheme Project Grants

Notes Standard Project Grant

Viewed: [[ro.stat.viewed]]